Abstract Library

#3953 Olaparib use in a patient diagnosed with BRCA2 mutated adrenocortical carcinoma: A case report

Introduction: Adrenocortical carcinoma (ACC) is a highly lethal endocrine malignancy with an estimated annual incidence of 1.5–2 cases per million. Only a small percentage of ACC cases are associated with hereditary cancer syndromes while, equally only a few cases, have been reported with BRCA mutation. Targeted therapy of ACC with germline mutations is an area of research which renders the treatment approach challenging.

Conference:

Presenting Author:

Authors: Kontana E, Tikas I, Boudina M, Chrysoulidou A, Andreadou A,

Keywords: adrenocortical carcinoma, brca2 mutation, olaparib,

#3676 Digestive neuroendocrine tumors – A retrospective study (nine cases)

Introduction: Digestive NETs are rare 1 to 2% of all digestive tumors and constitute a heterogeneous group of neoplastic lesions which differ from each other by their secretory and functional properties, pathogenic mechanisms, clinical presentations, evolution and their prognosis.

Conference:

Presenting Author:

Authors: Boudinar F, Larbaoui B,

Keywords: Digestive NETs, neuroendocrine carcinoma, epidemiology, NET,

#771 Liver Metastases in a Patient with G1 Gastric Carcinoid

Introduction: G1 gastric carcinoids are neuroendocrine tumors that rarely metastasize and have excellent prognosis.

Conference: 10th Annual ENETSConcerence (2013)

Presenting Author:

Authors: Mandanas S, Chrisoulidou A, Boudina M, Margaritidou E, Pilpilidis I,

Keywords: liver metastases, gastric carcinoids,

#767 Pancreatic NET Tumors Presenting with Hypercalcitonemia

Introduction: Pancreatic neuroendocrine tumors (pNET) secrete a variety of hormones, but calcitonin secretion rarely occurs.

Conference: 10th Annual ENETSConcerence (2013)

Presenting Author:

Authors: Chrisoulidou A, Pazaitou-Panayiotou K, Mandanas S, Chatzelis E, Boudina M,

Keywords: pancreatic, neuroendocrine tumor, calcitonin,